Sign in

CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company

Phathom Pharmaceuticals, Inc.

Sign in to watch
Ticker
PHAT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
824151574
Phone
(877) 742-8466
Business address
100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
  1. 4 Grant or award Chief Financial & Bus. Officer acquired 82,715 shares (grant or award)
  2. 4 Option exercise Director acquired 8,750 shares (option exercise)
  3. 4 Shares withheld for taxes Principal Accounting Officer gave up 230 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Legal Off. & Corp. Sec. gave up 7,703 shares (to pay taxes)
  5. 4 Shares withheld for taxes President and CEO gave up 31,502 shares (to pay taxes)
  6. 4 Shares withheld for taxes President and CEO gave up 48,375 shares (to pay taxes)
  7. 4 Open-market sale Principal Accounting Officer sold 524 shares at $13.51 ($7,079)
  8. 4/A Grant or award Chief Financial & Bus. Officer acquired 144,000 shares (grant or award)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Shares withheld for taxes President and CEO gave up 48,375 shares (to pay taxes)
  12. 4 Open-market sale Principal Accounting Officer sold 461 shares at $12.09 ($5,573)
  13. 4 Open-market sale Principal Accounting Officer sold 1,692 shares at $8.36 ($14,152)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Grant or award Director acquired 10,500 shares (grant or award)
  17. 4 Grant or award Director acquired 10,500 shares (grant or award)
  18. 4 Grant or award Director acquired 10,500 shares (grant or award)
  19. 4 Grant or award Director acquired 10,500 shares (grant or award)
  20. 4 Grant or award Director acquired 10,500 shares (grant or award)

Page 2 of 12 · 224 filings